Communiqués Brain+ A/S

Actions

BRAINP

DK0061670205

Marché Fermé - Nasdaq Copenhagen Autres places de cotation 15:00:50 31/05/2024			Varia. 5j.	Varia. 1 janv.
0,092 ^DKK	+3,37 %		-3,16 %	-52,58 %

22/05	Brain+ A/S annonce l'élection de Tim Juergens en tant que nouveau membre du conseil d'administration et président	CI
07/05	Brain+ prévoit une émission de droits de 9 millions de couronnes danoises pour aider à financer les opérations	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Brain+ A/S: Publication of investment brochure	31/05	AQ
Brain+' invites to online investor event with new Chairman	24/05	AQ
Minutes of Annual General Meeting in Brain+	22/05	AQ
Brain+ informs of progress on its UK focused proof-of-business strategy plan	16/05	AQ
Brain+ A/S convenes the Annual General Meeting	07/05	AQ
Brain+ publishes its Annual Report for 2023 - A year of market access, product development and a refocused commercial strategy	07/05	AQ
Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan	07/05	AQ
Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark	02/05	AQ
Brain+' CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia	30/04	AQ
Brain+ releases preliminary annual financial statements for 2023	30/04	AQ
Brain+ announces a change in its Financial Calendar for 2024	29/04	AQ
Successful educational CST course held with Malteser Germany based on the CST-Assistant	26/04	AQ
Brain+ announces registration of directed issue with the Danish Business Authority	11/04	AQ
Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority	10/04	AQ
Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments	26/03	AQ
Brain+ A/S specifies how to get TO 3 warrant compensation	26/03	AQ
Brain+ A/S announces last day of trading in its warrants of series TO 3	20/03	AQ
Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK	19/03	AQ
Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025	18/03	AQ
Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments	15/03	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Brain+ A/S

Actions

BRAINP

DK0061670205

Communiqués

Filtres